Yu P - Search Results

1

Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.

Yu P, Lee Y, Wang Y, Liu X, Auh S, Gajewski TF, Schreiber H, You Z, Kaynor C, Wang X, Fu YX. Yu P, et al. J Immunol. 2007 Aug 1;179(3):1960-8. doi: 10.4049/jimmunol.179.3.1960. J Immunol. 2007. PMID: 17641063 Free PMC article.

2

Priming of naive T cells inside tumors leads to eradication of established tumors.

Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. Yu P, et al. Nat Immunol. 2004 Feb;5(2):141-9. doi: 10.1038/ni1029. Epub 2004 Jan 4. Nat Immunol. 2004. PMID: 14704792 Free article.

3

Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion.

Wang YG, Kim KD, Wang J, Yu P, Fu YX. Wang YG, et al. Among authors: yu p. J Immunol. 2005 Nov 15;175(10):6997-7002. doi: 10.4049/jimmunol.175.10.6997. J Immunol. 2005. PMID: 16272360

4

Targeting tumors with LIGHT to generate metastasis-clearing immunity.

Yu P, Fu YX. Yu P, et al. Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):285-94. doi: 10.1016/j.cytogfr.2008.04.004. Epub 2008 May 27. Cytokine Growth Factor Rev. 2008. PMID: 18508404 Free PMC article. Review.

5

Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition.

Wang Y, Zhu M, Yu P, Fu YX. Wang Y, et al. Among authors: yu p. J Immunol. 2010 Feb 1;184(3):1589-95. doi: 10.4049/jimmunol.0901582. Epub 2009 Dec 30. J Immunol. 2010. PMID: 20042587

6

B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.

Yu P, Wang Y, Chin RK, Martinez-Pomares L, Gordon S, Kosco-Vibois MH, Cyster J, Fu YX. Yu P, et al. J Immunol. 2002 May 15;168(10):5117-23. doi: 10.4049/jimmunol.168.10.5117. J Immunol. 2002. PMID: 11994465

7

The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.

Wang J, Foster A, Chin R, Yu P, Sun Y, Wang Y, Pfeffer K, Fu YX. Wang J, et al. Among authors: yu p. Eur J Immunol. 2002 Jul;32(7):1969-79. doi: 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M. Eur J Immunol. 2002. PMID: 12115617 Free article.

8

Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.

Yu P, Spiotto MT, Lee Y, Schreiber H, Fu YX. Yu P, et al. J Exp Med. 2003 Apr 21;197(8):985-95. doi: 10.1084/jem.20021804. Epub 2003 Apr 14. J Exp Med. 2003. PMID: 12695490 Free PMC article.

9

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.

Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX. Yu P, et al. J Exp Med. 2005 Mar 7;201(5):779-91. doi: 10.1084/jem.20041684. J Exp Med. 2005. PMID: 15753211 Free PMC article.

10

Tumor-infiltrating T lymphocytes: friends or foes?

Yu P, Fu YX. Yu P, et al. Lab Invest. 2006 Mar;86(3):231-45. doi: 10.1038/labinvest.3700389. Lab Invest. 2006. PMID: 16446705 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,492 results

Search Page

Filters